PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
8321736-1	1993	STUDY OBJECTIVE: To compare the clinical safety and efficacy of ramipril, a new long-acting nonsulfhydryl inhibitor of angiotensin-converting enzyme (ACE), with enalapril.	Ramipril	64-72	angiotensin I converting enzyme	Homo sapiens	119-148	
8321736-1	1993	STUDY OBJECTIVE: To compare the clinical safety and efficacy of ramipril, a new long-acting nonsulfhydryl inhibitor of angiotensin-converting enzyme (ACE), with enalapril.	Ramipril	64-72	angiotensin I converting enzyme	Homo sapiens	150-153	
8321736-13	1993	A larger average decrease in plasma ACE activity was achieved with ramipril over all dosages (71%) compared with that for enalapril (48%), suggesting that ramipril has greater ACE inhibition in the circulation.	Ramipril	67-75	angiotensin I converting enzyme	Homo sapiens	36-39	
8321736-13	1993	A larger average decrease in plasma ACE activity was achieved with ramipril over all dosages (71%) compared with that for enalapril (48%), suggesting that ramipril has greater ACE inhibition in the circulation.	Ramipril	155-163	angiotensin I converting enzyme	Homo sapiens	36-39	
8321736-13	1993	A larger average decrease in plasma ACE activity was achieved with ramipril over all dosages (71%) compared with that for enalapril (48%), suggesting that ramipril has greater ACE inhibition in the circulation.	Ramipril	155-163	angiotensin I converting enzyme	Homo sapiens	176-179